Myung Hyun Lee1, Eun-Gyo Jeong1, Ji Yeun Chang1, Yaeni Kim1, Ji-Il Kim2, In Sung Moon2, Bum Soon Choi1, Cheol Whee Park1, Chul Woo Yang1, Yong-Soo Kim1, Byung Ha Chung3. 1. Transplant Research Center, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Nephrology, Department of Internal Medicine, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 2. Transplant Research Center, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Surgery, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 3. Transplant Research Center, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Nephrology, Department of Internal Medicine, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: chungbh@catholic.ac.kr.
Abstract
PURPOSE: In this study, we investigated the outcome of kidney transplantation (KT) from deceased donors with acute kidney injury (AKI), as defined by the Acute Kidney Injury Network criteria. METHODS: Of 156 deceased donors, kidneys from 43 donors (27.6%) with AKI were transplanted into 57 recipients (AKI group). Another 147 recipients received kidneys from donors without AKI (non-AKI group). We compared the incidence of delayed graft function, allograft function for 1 year after KT, and long-term (5 and 10 years) graft survival rate between the 2 groups. RESULTS: Delayed graft function developed more frequently in the AKI group than in the non-AKI group (42.1% vs 12.2%; P<.05), and allograft function-assessed by the modification of diet in renal disease equation-showed a significantly deteriorating pattern at 2 weeks and 1, 3, and 6 months after KT compared with that in the non-AKI group (P<.05 for comparisons at each time point). However, allograft function at 12 months after KT and the long-term allograft and patient survival rates did not differ between the AKI and non-AKI groups. CONCLUSIONS: In KT from deceased donors, the AKI group that received kidneys with AKI, as defined by the Acute Kidney Injury Network criteria, showed a higher delayed graft function rate and lower allograft function for 6 months after KT but no effect on allograft function 1 year after KT and on long-term allograft survival.
PURPOSE: In this study, we investigated the outcome of kidney transplantation (KT) from deceased donors with acute kidney injury (AKI), as defined by the Acute Kidney Injury Network criteria. METHODS: Of 156 deceased donors, kidneys from 43 donors (27.6%) with AKI were transplanted into 57 recipients (AKI group). Another 147 recipients received kidneys from donors without AKI (non-AKI group). We compared the incidence of delayed graft function, allograft function for 1 year after KT, and long-term (5 and 10 years) graft survival rate between the 2 groups. RESULTS: Delayed graft function developed more frequently in the AKI group than in the non-AKI group (42.1% vs 12.2%; P<.05), and allograft function-assessed by the modification of diet in renal disease equation-showed a significantly deteriorating pattern at 2 weeks and 1, 3, and 6 months after KT compared with that in the non-AKI group (P<.05 for comparisons at each time point). However, allograft function at 12 months after KT and the long-term allograft and patient survival rates did not differ between the AKI and non-AKI groups. CONCLUSIONS: In KT from deceased donors, the AKI group that received kidneys with AKI, as defined by the Acute Kidney Injury Network criteria, showed a higher delayed graft function rate and lower allograft function for 6 months after KT but no effect on allograft function 1 year after KT and on long-term allograft survival.
Authors: Isaac E Hall; Enver Akalin; Jonathan S Bromberg; Mona D Doshi; Tom Greene; Meera N Harhay; Yaqi Jia; Sherry G Mansour; Sumit Mohan; Thangamani Muthukumar; Peter P Reese; Bernd Schröppel; Pooja Singh; Heather R Thiessen-Philbrook; Francis L Weng; Chirag R Parikh Journal: Kidney Int Date: 2018-11-20 Impact factor: 10.612
Authors: I E Hall; B Schröppel; M D Doshi; J Ficek; F L Weng; R D Hasz; H Thiessen-Philbrook; P P Reese; C R Parikh Journal: Am J Transplant Date: 2015-03-11 Impact factor: 8.086
Authors: Urs Benck; Peter Schnuelle; Bernd Krüger; Kai Nowak; Thomas Riester; Heiko Mundt; Niklas Lutz; Matthias Jung; Rainer Birck; Bernhard K Krämer; Wilhelm H Schmitt Journal: Int Urol Nephrol Date: 2015-10-26 Impact factor: 2.370
Authors: Jeong Ho Kim; Young Soo Kim; Min Seok Choi; Young Ok Kim; Sun Ae Yoon; Ji-Il Kim; In Sung Moon; Bum Soon Choi; Cheol Whee Park; Chul Woo Yang; Yong-Soo Kim; Byung Ha Chung Journal: BMC Nephrol Date: 2017-01-27 Impact factor: 2.388
Authors: Jana Bauer; Sascha Grzella; Malwina Bialobrzecka; Lea Berger; Timm H Westhoff; Richard Viebahn; Peter Schenker Journal: Ann Transplant Date: 2018-12-07 Impact factor: 1.530
Authors: Kyung Jai Ko; Young Hwa Kim; Mi Hyeong Kim; Kang Woong Jun; Kyung Hye Kwon; Hyung Sook Kim; Sang Dong Kim; Sun Cheol Park; Ji Il Kim; Sang Seob Yun; In Sung Moon; Jeong Kye Hwang Journal: Ann Surg Treat Res Date: 2018-10-25 Impact factor: 1.859
Authors: Neel Koyawala; Peter P Reese; Isaac E Hall; Yaqi Jia; Heather R Thiessen-Philbrook; Sherry G Mansour; Mona D Doshi; Enver Akalin; Jonathan S Bromberg; Meera N Harhay; Sumit Mohan; Thangamani Muthukumar; Bernd Schröppel; Pooja Singh; Francis L Weng; Chirag R Parikh Journal: Transplantation Date: 2020-06 Impact factor: 5.385